The diabetic cardiomyopathy was established, diabetic cardiomyopathy rats were treated with Phase II enzyme inducer (CPDT), and the miR-503, Nrf2, and downstream medium level were detected and analyzed. Here, NFE2L2 is linked to diabetic cardiomyopathy.